A repurposed drug reduced exertional desaturation and dyspnea by 62% and 27%, respectively, in patients with Covid-19 pulmonary sequelae, according to a recent Phase 3 study. In patients with ...
Dear Doctors: I’ve been an endurance athlete my whole adult life. After having COVID-19, I’ve gone from running marathons at an 8-minute mile pace to needing walking breaks whenever I run. Are there ...
A new study suggests preload deficiency could be the underlying cause of fatigue and exercise intolerance in people with systemic lupus erythematosus (SLE). Preload deficiency is a condition where the ...
DEAR DOCTORS: I’ve been an endurance athlete my whole adult life. After having COVID-19, I’ve gone from running marathons at an 8-minute mile pace to needing walking breaks whenever I run. Are there ...
Petrovax announced today the positive results from “Long-CoV-III-21,” a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of bovhyaluronidase azoximer in adult ...
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study Participants consisted of 1,041 people who had survived cancer ≥ 10 years (and had or did ...
To earn CME related to this news article, click here. January 21, 2009 (Rochester, Minnesota) — Diastolic dysfunction is independently and strongly related to reduced exercise capacity, a new ...
In idiopathic pulmonary fibrosis, 12 months of pulmonary rehabilitation increased cerebral oxygenation during exercise, improved VO₂peak and workload, reduced anxiety and depression scores, and raised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback